Mani Vasudevan, Sajid Sultan, Rabbani Syed Imam, Alqasir Abdulrahman Saud, Alharbi Hani Abdullah, Alshumaym Abdullah
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
J Tradit Complement Med. 2021 May 1;11(6):493-502. doi: 10.1016/j.jtcme.2021.04.003. eCollection 2021 Nov.
Terminalia chebula (T.chebula) fruit is referred as "King of Medicines" in Tibet and is listed as a key plant in "Ayurvedic Materia Medica" due to its diverse pharmacological activity. The present study was aimed to investigate the comorbid antidepressant-like and anxiolytic-like effects of ethanol extract from T.chebula fruit using experimental behavioral tests in mice. In addition, the study explored the effects of extract on monoamine oxidase -A (MAO-A) levels in mouse brain. Two doses of the T.chebula extract (100 or 200 mg/kg, p.o.) were treated continuously for fifteen days to mice. Regarding antidepressant-like effects, the treatment of T.chebula extract at both dose (100 or 200 mg/kg, p.o.) levels resulted with significant (p < 0.001) reduction in duration of immobility time and increase in swimming time as compared to control group in forced swimming test. Moreover, both doses declined the duration of immobility time in the tail suspension test and increased the number of crossing in the center area using open-field test. Additionally, the dose 200 mg/kg treatment showed a significant reduction (p < 0.05) in MAO-A activity in mouse brain. For anxiolytic activity, both doses significantly (p < 0.001) improved the time spent in open arm and the number of head dips in elevated plus maze test. The higher duration of time spent in light chamber and higher number of crossing between the light and dark chambers by extract treatment in light-dark box test also supported the anxiolytic behavior. The obtained results supported the antidepressant-like and anxiolytic-like effects of ethanol extract of T.chebula in mice.
诃子果实在西藏被称为“药中之王”,因其多样的药理活性而被列为《阿育吠陀本草》中的关键植物。本研究旨在通过小鼠实验行为测试,研究诃子果实乙醇提取物的抗抑郁样和抗焦虑样共病效应。此外,该研究还探讨了提取物对小鼠大脑中单胺氧化酶 -A(MAO-A)水平的影响。给小鼠连续15天口服两种剂量的诃子提取物(100或200毫克/千克)。在抗抑郁样效应方面,与对照组相比,两种剂量(100或200毫克/千克,口服)的诃子提取物处理均导致强迫游泳试验中的不动时间显著减少(p < 0.001),游泳时间增加。此外,两种剂量均缩短了悬尾试验中的不动时间,并增加了旷场试验中在中央区域的穿越次数。此外,200毫克/千克剂量的处理使小鼠大脑中的MAO-A活性显著降低(p < 0.05)。在抗焦虑活性方面,两种剂量均显著(p < 0.001)增加了高架十字迷宫试验中在开放臂的停留时间和头部浸入次数。在明暗箱试验中,提取物处理使在明室停留的时间更长,在明暗室之间的穿越次数更多,这也支持了抗焦虑行为。所得结果支持诃子乙醇提取物对小鼠具有抗抑郁样和抗焦虑样效应。